Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 3Phase NA 1Phase 2/3 1

Status

Active not recruiting 4Recruiting 2Completed 2Terminated 1

Sponsor Class

INDUSTRY 5OTHER 3NETWORK 1

Study Type

Interventional 9

Sponsor

Cancer Type

Thoracic 5Gynecologic 2Head & Neck 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Non Small Cell Lung Carcinoma NSCLC 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Lung Neoplasms 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Specimen Handling 641pembrolizumab 585Magnetic Resonance Spectroscopy 555Carboplatin 431Cyclophosphamide 381Cisplatin 379Biopsy 376Nivolumab 315Paclitaxel 314Gemcitabine 308Radiotherapy 286Bevacizumab 235Dexamethasone 218fludarabine 206Docetaxel 194durvalumab 189Oxaliplatin 189venetoclax 187Rituximab 175Fluorouracil 175atezolizumab 172Pemetrexed 167Capecitabine 164Radiosurgery 162Doxorubicin 162Radiation 160Ipilimumab 146Lenalidomide 140Leucovorin 138Etoposide 134

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

9 trials
RecentStart dateEnrollment
CP protocol × 90 days × Clear all
NCT05294900 2026-05-26

NEOS

Yonsei University

Phase 2 Completed
79 enrolled 6 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05061550 2026-05-22

NeoCOAST-2

AstraZeneca

Phase 2 Recruiting
630 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06102252 2026-05-22

Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma

Sohag University

Phase NA Completed
60 enrolled
Gynecologic

Endometrial Neoplasms

NCT07365319 2026-05-20

TeLuRide-008

Eikon Therapeutics

Phase 2/3 Recruiting
750 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02453282 2026-05-12

MYSTIC

AstraZeneca

Phase 3 Active not recruiting
1,118 enrolled 40 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03609047 2026-05-12

Appalaches

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
366 enrolled
Breast

Breast Neoplasms

NCT02542293 2026-05-01

NEPTUNE

AstraZeneca

Phase 3 Active not recruiting
953 enrolled 29 charts
Thoracic

Non Small Cell Lung Carcinoma NSCLC

NCT04016142 2026-03-18

ACCRAPAN

Centre Oscar Lambret

Phase 2 Terminated
21 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT03003962 2026-03-11

Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)

AstraZeneca

Phase 3 Active not recruiting
669 enrolled 54 charts
Thoracic

Non Small Cell Lung Carcinoma NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡